Send me a link:

*Text messaging rates may apply.

 Dow Down0.11% Nasdaq Up0.44%

More On P31.SI



News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


Pharmesis International Ltd. (P31.SI)

0.04 0.00(0.00%) Jul 22
ProfileGet Profile for:
Pharmesis International Ltd.
No. 8 Yingbin Road
China - Map

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, health tonic products, and traditional Chinese medicine (TCM) formulated products in the People’s Republic of China. The company operates through Western Drugs, TCM Formulated Drugs, and Distribution segments. It is also involved in the wholesale of chemical drugs, biological raw products, TCMs, antibiotics, and antibiotics agents. The company offers its western medicines and TCM formulated products in the form of tablets, granules, pills, etc. Its products comprise Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi tablets for the treatment of flatus, inappetency, dyspepsy, and spleen weakness; and LianPu ShuangQing for the treatment of acute inflammation, such as dysentery and intestinal infection. Pharmesis International Ltd. also offers Shulinghou tablets, which clear heat and regenerate body fluid, as well as for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Er Ding granules for the treatment of jaundice, as well as clears heat toxics; and AFenKa for the treatment of migrane, pain, headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. In addition, the company provides Wuling Jiao Nang granules, which disperse water accumulation, regulate water circulation, and dispel dampness; Bear Bile and Bulbus Fritillariae oral liquid for the treatment of phlegmheat cough; and Gansu for the treatment of acute and chronic hepatitis. Pharmesis International Ltd. markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to approximately 2,000 hospitals through its sales and marketing personnel. The company was founded in 1996 and is headquartered in Chengdu, the People’s Republic of China.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Pharmesis International Ltd.

Key Executives 
Mr. Xuedan Wu , 51
Chief Exec. Officer, Exec. Director and Member of Nominating Committee
Ms. Siaw Yean Tee , 38
Financial Controller
Dr. Deng Zemin ,
Head of Research
Ms. Siew Tian Low ACIS,
Joint Company Sec.
Ms. Lai Yin Chan ,
Joint Company Sec.
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in SGD.